Anti-Aging Treatments Available Through Telehealth in 2026

The anti-aging treatments commonly offered through telehealth are NAD+ injections, glutathione injections, peptides such as sermorelin, and hormone therapy. Only hormone therapy includes FDA-approved products, and those are approved for specific medical conditions, not for aging itself; the rest are compounded drugs that FDA has not approved and whose human evidence is thin.

That distinction matters more than any brand name. FDA states plainly that compounded drugs are not FDA-approved and that it does not verify their safety, effectiveness or quality before they are marketed. Drugs from a 503B outsourcing facility must follow current good manufacturing practice (CGMP) rules and are inspected mainly by FDA; drugs from a 503A pharmacy are not held to CGMP and are overseen day to day by state boards of pharmacy. Asking a clinic which kind of pharmacy fills its prescriptions is a reasonable first question.

NAD+ Therapy

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme the body uses in energy metabolism. Clinics sell it as an injection or IV drip made by compounding pharmacies, while NMN and NR are oral precursors sold as supplements. The human research is small. A 2024 systematic review in the American Journal of Physiology: Endocrinology and Metabolism found 10 studies with 489 participants in total, all using oral NADH or NAD precursors rather than injections. Reported side effects included muscle pain, fatigue, sleep disturbance and headaches, none judged serious, and the authors called for more research on specific conditions and doses.

Results for the aging-related outcomes people usually care about have been modest. A 2025 meta-analysis of randomized trials in adults averaging over 60 found that NMN had no significant effect on muscle mass, grip strength or walking speed, and NR gave mixed results; the authors concluded that current evidence does not support NMN or NR for preserving muscle mass and function. Because neither review covered injected NAD+, human data on the form most telehealth clinics sell is thinner still.

Glutathione Injections

Glutathione is an antioxidant the body makes on its own. Injectable glutathione sold by clinics is compounded, so it falls under the same FDA caveat as any compounded drug. The most important recent fact is a safety notice: in August 2026 FDA said it was aware of at least 30 patients who had adverse events after IV glutathione, given alone or mixed with other ingredients, including fever, chills, pain, dizziness, signs of shock and sepsis-like symptoms. Some patients were hospitalized. FDA said the symptoms were consistent with excessive endotoxin exposure and that the glutathione involved was labeled dietary supplement grade, which it called an inappropriate ingredient for injectable drugs. FDA also noted it had raised similar concerns in 2019.

Peptide Therapy

Sermorelin is the peptide with the clearest regulatory history. It was once sold as the FDA-approved injection Geref, which was later withdrawn from sale; in 2013 FDA determined that the withdrawal was not for reasons of safety or effectiveness. The sermorelin telehealth clinics prescribe today is compounded, so it is not FDA-approved.

Many other peptides marketed for longevity appear on FDA's page of bulk drug substances that may present significant safety risks (content current as of April 22, 2026). BPC-157, GHK-Cu for injection, thymosin alpha-1, CJC-1295, epitalon and MOTs-C are listed as nominated but withdrawn. FDA's notes include limited human safety data for injectable GHK-Cu, inadequate safety information for thymosin alpha-1, and serious adverse events including increased heart rate for CJC-1295. Ipamorelin is in category 2 for 503B facilities, with FDA citing serious adverse events including death when it was given intravenously. An earlier version of this guide said February 2026 rule changes had restored access to 14 peptides; the FDA pages we checked do not show that, so we removed the claim.

Hormone Therapy

For menopause, FDA says hormone therapy can help hot flashes, night sweats and vaginal dryness and may lower the risk of osteoporosis, but it is not for everyone. For some women it may raise the chance of blood clots, heart attack, stroke, breast cancer and gallbladder disease. FDA advises using the lowest dose that helps for the shortest time needed, and says it has no evidence that compounded "bioidentical" hormones are safer or more effective than FDA-approved products, which already contain hormones identical to those the body makes.

For men, testosterone is a Schedule III controlled substance. The testosterone cypionate label says safety and efficacy have not been established for "age-related hypogonadism", meaning low testosterone due to aging alone. In February 2025 FDA required class-wide label changes: results of the TRAVERSE trial, which found no increase in adverse cardiovascular outcomes in men using testosterone for hypogonadism, were added; cardiovascular-risk language was removed from the boxed warning; blood pressure warnings were added; and the limitation of use for age-related hypogonadism was kept. Because it is a controlled substance, federal and state rules govern how testosterone can be prescribed, including over telehealth.

• •Hormone therapy: FDA-approved products exist for menopause symptoms and for low testosterone caused by a medical condition. Not approved for aging itself; compounded versions are not FDA-approved.
• •NAD+: Injections are compounded and not FDA-approved. Published human studies are small and mostly use oral NADH, NMN or NR.
• •Glutathione: Injections are compounded and not FDA-approved. FDA issued a safety notice about contaminated IV glutathione in August 2026.
• •Peptides: Compounded sermorelin is widely offered. Several other popular peptides are on FDA's safety-risk list; check that page for current status.

What It Costs

Prices vary widely by clinic, product and dose, and many clinics bundle a membership fee, lab work and medication differently, so we do not quote a single range here. Before paying, ask for the ongoing monthly price after any introductory offer, what lab tests are required and what they cost, and how to cancel. Our individual anti-aging provider reviews list the plans each provider publishes.

1. 1.Is this product FDA-approved for my condition, or is it compounded?
2. 2.Which pharmacy prepares it, and is it a 503A pharmacy or a 503B outsourcing facility?
3. 3.What does the clinic know about the human evidence for this treatment, and what outcome should I expect to measure?
4. 4.Is the peptide or ingredient on FDA's list of bulk substances that may present significant safety risks?
5. 5.What blood tests are done before and during treatment, and who reviews them?
6. 6.What is the full ongoing monthly cost, and how do I cancel?